1 Min Read
Nov 16 (Reuters) - Spero Therapeutics Inc
* GlaxoSmithKline PLC reports a 13.3 percent stake in Spero Therapeutics Inc as of November 6 - SEC filing Source text: (bit.ly/2infUEI) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.